Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myasthenia Gravis | 5 | 2024 | 15 | 1.710 |
Why?
|
| Muscle Weakness | 2 | 2018 | 34 | 0.650 |
Why?
|
| Myotonic Dystrophy | 4 | 2025 | 5 | 0.600 |
Why?
|
| Quality of Life | 5 | 2024 | 971 | 0.580 |
Why?
|
| Myositis | 1 | 2018 | 10 | 0.570 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 70 | 0.550 |
Why?
|
| Azathioprine | 1 | 2024 | 27 | 0.410 |
Why?
|
| Mycophenolic Acid | 1 | 2024 | 42 | 0.410 |
Why?
|
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2012 | 6 | 0.370 |
Why?
|
| Sodium Channels | 2 | 2012 | 16 | 0.370 |
Why?
|
| Mexiletine | 2 | 2020 | 2 | 0.350 |
Why?
|
| Rejuvenation | 1 | 2011 | 1 | 0.340 |
Why?
|
| Neoplasms | 1 | 2018 | 763 | 0.340 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2011 | 3 | 0.340 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 246 | 0.330 |
Why?
|
| Hand | 1 | 2011 | 81 | 0.330 |
Why?
|
| Thyrotoxicosis | 1 | 2010 | 1 | 0.330 |
Why?
|
| Hypokalemic Periodic Paralysis | 1 | 2010 | 1 | 0.330 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2010 | 10 | 0.320 |
Why?
|
| Ataxia | 2 | 2022 | 5 | 0.300 |
Why?
|
| Humans | 19 | 2025 | 32284 | 0.260 |
Why?
|
| Muscle, Skeletal | 5 | 2018 | 520 | 0.230 |
Why?
|
| Male | 13 | 2025 | 19434 | 0.220 |
Why?
|
| Myokymia | 1 | 2014 | 1 | 0.210 |
Why?
|
| Adult | 10 | 2025 | 9263 | 0.200 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 146 | 0.200 |
Why?
|
| Myotonia | 1 | 2012 | 1 | 0.190 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 17 | 0.190 |
Why?
|
| Cohort Studies | 4 | 2020 | 1840 | 0.180 |
Why?
|
| Female | 12 | 2025 | 19954 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2025 | 293 | 0.170 |
Why?
|
| Electrodiagnosis | 2 | 2018 | 41 | 0.170 |
Why?
|
| Kidney | 1 | 2025 | 520 | 0.170 |
Why?
|
| Adolescent | 6 | 2024 | 3521 | 0.160 |
Why?
|
| Hand Strength | 1 | 2020 | 98 | 0.160 |
Why?
|
| Creatine Kinase | 2 | 2017 | 7 | 0.160 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 851 | 0.150 |
Why?
|
| Cortactin | 1 | 2018 | 1 | 0.140 |
Why?
|
| Kv1.1 Potassium Channel | 2 | 2022 | 5 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 18 | 0.140 |
Why?
|
| Receptors, Cholinergic | 1 | 2018 | 26 | 0.140 |
Why?
|
| Paralyses, Familial Periodic | 1 | 2018 | 1 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2018 | 50 | 0.140 |
Why?
|
| Middle Aged | 8 | 2025 | 11843 | 0.140 |
Why?
|
| Bayes Theorem | 1 | 2018 | 83 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2024 | 2320 | 0.130 |
Why?
|
| Exercise Test | 1 | 2018 | 218 | 0.130 |
Why?
|
| Arthrogryposis | 1 | 2016 | 2 | 0.130 |
Why?
|
| Hereditary Sensory and Motor Neuropathy | 1 | 2016 | 2 | 0.130 |
Why?
|
| Muscle Cramp | 1 | 2016 | 4 | 0.120 |
Why?
|
| Neural Conduction | 1 | 2016 | 82 | 0.120 |
Why?
|
| Muscle Strength | 2 | 2015 | 136 | 0.120 |
Why?
|
| Young Adult | 5 | 2015 | 2652 | 0.100 |
Why?
|
| Alternative Splicing | 1 | 2013 | 32 | 0.100 |
Why?
|
| Orphan Drug Production | 1 | 2012 | 1 | 0.090 |
Why?
|
| Paresthesia | 1 | 2012 | 8 | 0.090 |
Why?
|
| Spinal Nerve Roots | 1 | 2012 | 12 | 0.090 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 29 | 0.090 |
Why?
|
| Axons | 1 | 2012 | 35 | 0.090 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2012 | 24 | 0.090 |
Why?
|
| Brachial Plexus | 1 | 2012 | 28 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 46 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2024 | 248 | 0.090 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 38 | 0.090 |
Why?
|
| Biopsy | 1 | 2012 | 249 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2018 | 3612 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2010 | 20 | 0.080 |
Why?
|
| Histocytochemistry | 1 | 2010 | 34 | 0.080 |
Why?
|
| Electrophysiology | 1 | 2010 | 76 | 0.080 |
Why?
|
| Potassium | 1 | 2010 | 40 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2010 | 76 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2020 | 566 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2010 | 109 | 0.080 |
Why?
|
| Family | 1 | 2010 | 112 | 0.080 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2010 | 108 | 0.080 |
Why?
|
| Action Potentials | 1 | 2010 | 212 | 0.070 |
Why?
|
| Aged | 5 | 2017 | 10257 | 0.070 |
Why?
|
| Child | 2 | 2022 | 2446 | 0.070 |
Why?
|
| DNA | 1 | 2010 | 222 | 0.070 |
Why?
|
| Anterior Temporal Lobectomy | 1 | 2009 | 1 | 0.070 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2009 | 2 | 0.070 |
Why?
|
| Insulin | 1 | 2010 | 359 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1211 | 0.060 |
Why?
|
| Oculomotor Muscles | 1 | 2006 | 5 | 0.060 |
Why?
|
| Point Mutation | 1 | 2014 | 29 | 0.050 |
Why?
|
| Age of Onset | 1 | 2014 | 91 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 96 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2012 | 201 | 0.040 |
Why?
|
| Pain | 1 | 2012 | 303 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 1485 | 0.040 |
Why?
|
| Evoked Potentials, Motor | 1 | 2018 | 8 | 0.040 |
Why?
|
| Electromyography | 1 | 2018 | 67 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 169 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2020 | 624 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2015 | 30 | 0.030 |
Why?
|
| Absorptiometry, Photon | 1 | 2015 | 98 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 99 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 619 | 0.030 |
Why?
|
| Myotonic Disorders | 1 | 2013 | 3 | 0.030 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2013 | 24 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 67 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 149 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 254 | 0.020 |
Why?
|
| alpha-Glucosidases | 1 | 2012 | 2 | 0.020 |
Why?
|
| Tetrabenazine | 1 | 2012 | 3 | 0.020 |
Why?
|
| Spasms, Infantile | 1 | 2012 | 4 | 0.020 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2012 | 6 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2012 | 23 | 0.020 |
Why?
|
| Drug Approval | 1 | 2012 | 13 | 0.020 |
Why?
|
| Health Care Sector | 1 | 2012 | 18 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 441 | 0.020 |
Why?
|
| United States | 2 | 2012 | 4079 | 0.020 |
Why?
|
| Biological Products | 1 | 2012 | 79 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1073 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 1024 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2009 | 11 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 54 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 1 | 2009 | 72 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2009 | 69 | 0.020 |
Why?
|
| Mice | 1 | 2013 | 2544 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 818 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 8165 | 0.010 |
Why?
|